List of Tables
Table 1. Global Viral Vectors Gene Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Retro Viral Vectors
Table 3. Key Players of Adeno-associated Virus Vectors
Table 4. Key Players of Other Viral Vectors
Table 5. Global Viral Vectors Gene Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Viral Vectors Gene Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Viral Vectors Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Viral Vectors Gene Therapy Market Share by Region (2017-2022)
Table 9. Global Viral Vectors Gene Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Viral Vectors Gene Therapy Market Share by Region (2023-2028)
Table 11. Viral Vectors Gene Therapy Market Trends
Table 12. Viral Vectors Gene Therapy Market Drivers
Table 13. Viral Vectors Gene Therapy Market Challenges
Table 14. Viral Vectors Gene Therapy Market Restraints
Table 15. Global Viral Vectors Gene Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Viral Vectors Gene Therapy Market Share by Players (2017-2022)
Table 17. Global Top Viral Vectors Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors Gene Therapy as of 2021)
Table 18. Ranking of Global Top Viral Vectors Gene Therapy Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Viral Vectors Gene Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Viral Vectors Gene Therapy Product Solution and Service
Table 22. Date of Enter into Viral Vectors Gene Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Viral Vectors Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Viral Vectors Gene Therapy Revenue Market Share by Type (2017-2022)
Table 26. Global Viral Vectors Gene Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Viral Vectors Gene Therapy Revenue Market Share by Type (2023-2028)
Table 28. Global Viral Vectors Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Viral Vectors Gene Therapy Revenue Market Share by Application (2017-2022)
Table 30. Global Viral Vectors Gene Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Viral Vectors Gene Therapy Revenue Market Share by Application (2023-2028)
Table 32. North America Viral Vectors Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Viral Vectors Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Viral Vectors Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Viral Vectors Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Viral Vectors Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Viral Vectors Gene Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Viral Vectors Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Viral Vectors Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Viral Vectors Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Viral Vectors Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 42. Amgen Company Detail
Table 43. Amgen Business Overview
Table 44. Amgen Viral Vectors Gene Therapy Product
Table 45. Amgen Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 46. Amgen Recent Development
Table 47. Novartis Company Detail
Table 48. Novartis Business Overview
Table 49. Novartis Viral Vectors Gene Therapy Product
Table 50. Novartis Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Orchard Therapeutics Company Detail
Table 53. Orchard Therapeutics Business Overview
Table 54. Orchard Therapeutics Viral Vectors Gene Therapy Product
Table 55. Orchard Therapeutics Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 56. Orchard Therapeutics Recent Development
Table 57. Spark Therapeutics Company Detail
Table 58. Spark Therapeutics Business Overview
Table 59. Spark Therapeutics Viral Vectors Gene Therapy Product
Table 60. Spark Therapeutics Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 61. Spark Therapeutics Recent Development
Table 62. Agc Biologics Company Detail
Table 63. Agc Biologics Business Overview
Table 64. Agc Biologics Viral Vectors Gene Therapy Product
Table 65. Agc Biologics Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 66. Agc Biologics Recent Development
Table 67. Anges Company Detail
Table 68. Anges Business Overview
Table 69. Anges Viral Vectors Gene Therapy Product
Table 70. Anges Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 71. Anges Recent Development
Table 72. Bluebird Bio Company Detail
Table 73. Bluebird Bio Business Overview
Table 74. Bluebird Bio Viral Vectors Gene Therapy Product
Table 75. Bluebird Bio Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 76. Bluebird Bio Recent Development
Table 77. Jazz Pharmaceuticals Company Detail
Table 78. Jazz Pharmaceuticals Business Overview
Table 79. Jazz Pharmaceuticals Viral Vectors Gene Therapy Product
Table 80. Jazz Pharmaceuticals Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 81. Jazz Pharmaceuticals Recent Development
Table 82. Dynavax Technologies Company Detail
Table 83. Dynavax Technologies Business Overview
Table 84. Dynavax Technologies Viral Vectors Gene Therapy Product
Table 85. Dynavax Technologies Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 86. Dynavax Technologies Recent Development
Table 87. Biogen Company Detail
Table 88. Biogen Business Overview
Table 89. Biogen Viral Vectors Gene Therapy Product
Table 90. Biogen Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 91. Biogen Recent Development
Table 92. Sarepta Therapeutics Company Detail
Table 93. Sarepta Therapeutics Business Overview
Table 94. Sarepta Therapeutics Viral Vectors Gene TherapyProduct
Table 95. Sarepta Therapeutics Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 96. Sarepta Therapeutics Recent Development
Table 97. Gilead Sciences Company Detail
Table 98. Gilead Sciences Business Overview
Table 99. Gilead Sciences Viral Vectors Gene TherapyProduct
Table 100. Gilead Sciences Revenue in Viral Vectors Gene Therapy Business (2017-2022) & (US$ Million)
Table 101. Gilead Sciences Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors Gene Therapy Market Share by Type: 2021 VS 2028
Figure 2. Retro Viral Vectors Features
Figure 3. Adeno-associated Virus Vectors Features
Figure 4. Other Viral Vectors Features
Figure 5. Global Viral Vectors Gene Therapy Market Share by Application in 2021 & 2028
Figure 6. In Vivo Case Studies
Figure 7. Ex Vivo Case Studies
Figure 8. Viral Vectors Gene Therapy Report Years Considered
Figure 9. Global Viral Vectors Gene Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Viral Vectors Gene Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Viral Vectors Gene Therapy Market Share by Region: 2021 VS 2028
Figure 12. Global Viral Vectors Gene Therapy Market Share by Players in 2021
Figure 13. Global Top Viral Vectors Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors Gene Therapy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Viral Vectors Gene Therapy Revenue in 2021
Figure 15. North America Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Viral Vectors Gene Therapy Market Share by Country (2017-2028)
Figure 17. United States Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Viral Vectors Gene Therapy Market Share by Country (2017-2028)
Figure 21. Germany Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Viral Vectors Gene Therapy Market Share by Region (2017-2028)
Figure 29. China Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Viral Vectors Gene Therapy Market Share by Country (2017-2028)
Figure 37. Mexico Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Viral Vectors Gene Therapy Market Share by Country (2017-2028)
Figure 41. Turkey Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Viral Vectors Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Amgen Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 44. Novartis Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 45. Orchard Therapeutics Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 46. Spark Therapeutics Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 47. Agc Biologics Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 48. Anges Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 49. Bluebird Bio Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 50. Jazz Pharmaceuticals Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 51. Dynavax Technologies Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 52. Biogen Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 53. Sarepta Therapeutics Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 54. Gilead Sciences Revenue Growth Rate in Viral Vectors Gene Therapy Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
